These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 32666169
1. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement. Shi RY, An DA, Chen BH, Wu R, Du L, Jiang M, Xu JR, Wu LM. Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169 [Abstract] [Full Text] [Related]
6. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine. Liu D, Ma X, Liu J, Zhao L, Chen H, Xu L, Sun Z, Fan Z. Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991 [Abstract] [Full Text] [Related]
8. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG. Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954 [Abstract] [Full Text] [Related]
9. High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy. Shi RY, An DA, Chen BH, Wu R, Wu CW, Du L, Zhu J, Jiang M, Xu JR, Wu LM. Sci Rep; 2019 Feb 25; 9(1):2644. PubMed ID: 30804397 [Abstract] [Full Text] [Related]
13. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S. JACC Cardiovasc Imaging; 2013 Oct 25; 6(10):1048-1058. PubMed ID: 24011774 [Abstract] [Full Text] [Related]
16. Exercise and myocardial injury in hypertrophic cardiomyopathy. Cramer GE, Gommans DHF, Dieker HJ, Michels M, Verheugt F, de Boer MJ, Bakker J, Fouraux MA, Timmermans J, Kofflard M, Brouwer M. Heart; 2020 Aug 25; 106(15):1169-1175. PubMed ID: 32001622 [Abstract] [Full Text] [Related]
17. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Thompson EW, Kamesh Iyer S, Solomon MP, Li Z, Zhang Q, Piechnik S, Werys K, Swago S, Moon BF, Rodgers ZB, Hall A, Kumar R, Reza N, Kim J, Jamil A, Desjardins B, Litt H, Owens A, Witschey WRT, Han Y. J Cardiovasc Magn Reson; 2021 Oct 25; 23(1):120. PubMed ID: 34689798 [Abstract] [Full Text] [Related]
20. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young. Österberg AW, Östman-Smith I, Jablonowski R, Carlsson M, Green H, Gunnarsson C, Liuba P, Fernlund E. Pediatr Cardiol; 2021 Mar 25; 42(3):492-500. PubMed ID: 33515326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]